Lexology March 25, 2024
Ropes & Gray LLP

Click here to listen to the audio.

In this second installment of Ropes & Gray’s three-part podcast series exploring recent regulatory, compliance, and enforcement developments in the fraud, waste, and abuse space and the potential implications for health care and life science companies in 2024, health care partners Devin Cohen and Michael Lampert are joined by litigation & enforcement partner Andrew O’Connor for a conversation on remuneration offered and paid by labs. Topics of discussion include an exploration of the permissibility of specimen processing arrangements, and an examination of overlay between the Office of the Inspector General (“OIG”) advisory opinions and Department of Justice (“DOJ”) enforcement actions.

Transcript:

Devin Cohen: Hello, and welcome to today’s podcast. This is part two...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Govt Agencies, OIG, Provider, Trends
Cutting and pasting (aka cloned) EHR portions can lead to false claims
HHS-OIG Highlights Anti-Fraud Safeguards for Patient Assistance Programs Backed Mainly by Drug Manufacturers
Improper Payments in Medicare and Medicaid: Who's at Fault?
Only 8% of Medicaid and 4% of Medicare Enrollees Received Behavioral Health Services
OIG Targets Home Health Improper Payments, EVV, Consumer-Directed Programs in Ongoing Watchdog Initiatives

Share This Article